I feel the lack of HRT GDS share price performance is a reflection of a low float ( due to the R/S ) creating low liquidity resulting in disinterest in HRT shares by institutions and individual investors.
Thankfully the planned 30 to 1 R/S was defeated, admittedly 10 to 1 is better, ideally 5 to 1 R/S would have been the best way to go, if you are to have a R/S in the case of HRT,
Renzo and I fought hard against the 30 to 1 R/S and other company proposals. We may have had or no effect on the resulting outcome regarding the R/S, but we both worked hard together fighting for what we thought was best for the company and it's shareholders.
I personally am not pleased with the results of our efforts, I had hoped to have achieved more.
